compulsory licence

India grants first Compulsory licence to allow generic production and sale of a patented medicine The compulsory licence was granted under Section 90 of the Indian Patents Act, on 12th March 2012...

Web article – Last updated 10 April 2012
www.msfaccess.org/content/background-information-indias-first-compulsory-licence

Groundbreaking Move Sets Precedent for Overcoming Drug Price Barriers India 2008 © Jean-Marc Giboux/Getty Images 12 March 2012, New Delhi/Geneva – In a landmark case, the Indian...

Press Release – Last updated 12 April 2012
www.msfaccess.org/about-us/media-room/press-releases/india-issues-first-compulsory-licence

At the heart of almost every dispute about access to medicines lies this question: how do countries balance the need to protect public health against patent rights that lead to high medicine prices...

Op-eds & Articles – Last updated 22 November 2011
www.msfaccess.org/content/trade-and-public-health-decade-double-standards

Civil society files patent opposition to increase access to HIV/AIDS medicines Rio de Janeiro, 10 November 2011 – Brazilian civil society will oppose a patent application today for the key...

Press Release – Last updated 11 November 2011
www.msfaccess.org/about-us/media-room/press-releases/brazilians-demand-greater-access-crucial-hiv-drug

Every day, Médecins Sans Frontières (MSF) is confronted with the lack of access to adequate or affordable medical tools in the field. We face two major challenges the high cost of existing...

Report – Last updated 16 January 2009
www.msfaccess.org/content/global-politics-pharmaceutical-monopoly-power

The latest edition of Untangling the Web of Antiretroviral Price Reductions (UTW) released at the IAS 2011 in Rome demonstrates a growing and deadly divide in antiretroviral (ARV) prices offered to...

Report – Last updated 18 July 2011
www.msfaccess.org/content/untangling-web-antiretroviral-price-reductions-14th-edition

Each year, MSF publishes a survey of the latest prices for antiretroviral medicines to treat people living with HIV/AIDS in developing countries. It started out as a way of offering a practical guide...

Web article – Last updated 08 August 2011
www.msfaccess.org/content/caught-middle-%E2%80%93-hiv-medicines-pricing-sky-high-%E2%80%98middle-income%E2%80%99-countries

Access once again under threat Ten years after the Doha Declaration clarified countries’ sovereign right to take measures to protect public health, access to medicines remains under threat.   The...

Static page – Last updated 22 July 2011
www.msfaccess.org/content/what-needs-happen

In November 2006, Thailand announced its first ever decision to issue a compulsory licence for the antiretroviral efavirenz, which was patented and priced out of reach of patients in the country.  The...

Static page – Last updated 22 July 2011
www.msfaccess.org/content/2006-thailand-begins-issue-compulsory-licences

On 1st January 2005, the transitional period for India to start granting patents on medicines as required by the TRIPS Agreement came to an end, and the country had to change its law to make pharmaceutical...

Static page – Last updated 22 July 2011
www.msfaccess.org/content/2005-india-has-change-its-patent-law